Hematopoietic stem cell transplantation is effective for advanced lymphoma.
1. For those intermediate-risk diffuse large B-cell lymphoma and lymphoma with set cell, hematopoietic stem cell transplantation can significantly improve the prognosis and prolong the survival of patients.
2. For some extremely high-risk lymphoma types, such as aggressive lymphoma and lymphoma with condylomata, even if allogeneic hematopoietic stem cell transplantation is performed, the efficacy of the treatment is often unsatisfactory.
Therefore, for the treatment of lymphoma, accurate prognostic assessment before treatment is crucial, which can provide a theoretical basis for individualized treatment of patients. The decision of whether or not to undergo hematopoietic stem cell transplantation needs to be made by a professional physician.